IQBAL J HUSSAIN, the General Counsel of $CNTA, sold 6,000 shares of the company on 09-15-2025 for an estimated $131,100. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.4% of their shares of this class of stock. Following this trade, they now own 105,386 shares of this class of $CNTA stock.
$CNTA Insider Trading Activity
$CNTA insiders have traded $CNTA stock on the open market 30 times in the past 6 months. Of those trades, 2 have been purchases and 28 have been sales.
Here’s a breakdown of recent trading of $CNTA stock by insiders over the last 6 months:
- ARJUN GOYAL has made 2 purchases buying 462,585 shares for an estimated $5,865,242 and 0 sales.
- SAURABH SAHA (Chief Executive Officer) has made 0 purchases and 6 sales selling 275,000 shares for an estimated $3,869,172.
- IQBAL J HUSSAIN (General Counsel) has made 0 purchases and 10 sales selling 82,000 shares for an estimated $1,515,076.
- TIA L BUSH (Chief Technology & Quality Ofc) has made 0 purchases and 2 sales selling 49,792 shares for an estimated $1,045,840.
- GREGORY M WEINHOFF (Chief Business Officer) has made 0 purchases and 5 sales selling 51,742 shares for an estimated $745,707.
- MARIO ALBERTO ACCARDI (President, Orexin Program) has made 0 purchases and 3 sales selling 30,322 shares for an estimated $476,750.
- DAVID M CHAO (Chief Administrative Officer) has made 0 purchases and 2 sales selling 7,000 shares for an estimated $120,205.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CNTA Hedge Fund Activity
We have seen 64 institutional investors add shares of $CNTA stock to their portfolio, and 76 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VIDA VENTURES ADVISORS, LLC removed 3,931,818 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $56,539,542
- HOLOCENE ADVISORS, LP removed 2,255,679 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $29,639,622
- PERCEPTIVE ADVISORS LLC removed 1,893,460 shares (-62.3%) from their portfolio in Q2 2025, for an estimated $24,880,064
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,752,847 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $23,032,409
- RTW INVESTMENTS, LP added 1,479,836 shares (+2959.7%) to their portfolio in Q2 2025, for an estimated $19,445,045
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,449,000 shares (+20.8%) to their portfolio in Q2 2025, for an estimated $19,039,860
- BAKER BROS. ADVISORS LP removed 1,227,178 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $16,125,118
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CNTA Analyst Ratings
Wall Street analysts have issued reports on $CNTA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Chardan Capital issued a "Buy" rating on 08/12/2025
- Needham issued a "Buy" rating on 05/28/2025
- Piper Sandler issued a "Overweight" rating on 03/31/2025
- Guggenheim issued a "Buy" rating on 03/26/2025
To track analyst ratings and price targets for $CNTA, check out Quiver Quantitative's $CNTA forecast page.
$CNTA Price Targets
Multiple analysts have issued price targets for $CNTA recently. We have seen 6 analysts offer price targets for $CNTA in the last 6 months, with a median target of $30.5.
Here are some recent targets:
- Benjamin Burnett from Wells Fargo set a target price of $31.0 on 09/03/2025
- Rudy Li from Chardan Capital set a target price of $30.0 on 08/12/2025
- Danielle Brill from Truist Securities set a target price of $30.0 on 07/21/2025
- Ami Fadia from Needham set a target price of $35.0 on 05/28/2025
- Biren Amin from Piper Sandler set a target price of $38.0 on 03/31/2025
- Debjit Chattopadhyay from Guggenheim set a target price of $28.0 on 03/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
